152 related articles for article (PubMed ID: 1680495)
61. Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature.
Yablonski-Peretz T; Sulkes A; Polliack A; Weshler Z; Okon E; Catane R
Med Pediatr Oncol; 1985; 13(2):92-6. PubMed ID: 3982370
[TBL] [Abstract][Full Text] [Related]
62. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract][Full Text] [Related]
63. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
Asimakopoulos FA; Holloway TL; Nacheva EP; Scott MA; Fenaux P; Green AR
Blood; 1996 Feb; 87(4):1561-70. PubMed ID: 8608248
[TBL] [Abstract][Full Text] [Related]
64. bcr-abl-Induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro.
Elefanty AG; Cory S
Blood; 1992 Mar; 79(5):1271-81. PubMed ID: 1536951
[TBL] [Abstract][Full Text] [Related]
65. Myelonecrosis with agnogenic myeloid metaplasia.
Shankar SK; Joshi K; Ratnakar KS
J Assoc Physicians India; 1979 Apr; 27(4):354-6. PubMed ID: 528487
[No Abstract] [Full Text] [Related]
66. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia.
Wang JC; Lang HD; Lichter S; Weinstein M; Benn P
Br J Haematol; 1992 Feb; 80(2):184-8. PubMed ID: 1550774
[TBL] [Abstract][Full Text] [Related]
67. Chronic myeloid leukaemia masquerading as primary myelofibrosis.
Mohamed M; Beamish M; Grabek J
Pathology; 2014 Jan; 46(1):75-7. PubMed ID: 24300731
[No Abstract] [Full Text] [Related]
68. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
69. Granulopoiesis-supporting effects of marrow stromal cells in continuous culture from patients with primary myelofibrosis.
Hotta T; Murate T; Yamao H; Yamada H; Saito H
Br J Haematol; 1986 Dec; 64(4):669-73. PubMed ID: 3801318
[TBL] [Abstract][Full Text] [Related]
70. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
[TBL] [Abstract][Full Text] [Related]
71. High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension.
Popat U; Frost A; Liu E; Guan Y; Durette A; Reddy V; Prchal JT
Blood; 2006 May; 107(9):3486-8. PubMed ID: 16418333
[TBL] [Abstract][Full Text] [Related]
72. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
73. Chronic myeloproliferative disorders with myeloid metaplasia.
Kabukçuoğlu S
Am J Surg Pathol; 2000 Oct; 24(10):1437. PubMed ID: 11023109
[No Abstract] [Full Text] [Related]
74. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
Bartl R; Frisch B; Wilmanns W
Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
[TBL] [Abstract][Full Text] [Related]
75. Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.
Thiele J; Braeckel C; Wagner S; Falini B; Dienemann D; Stein H; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):33-9. PubMed ID: 1636247
[TBL] [Abstract][Full Text] [Related]
76. Nephrotic syndrome associated with agnogenic myeloid metaplasia.
Pamuk ON; Pamuk GE; Altiparmak MR; Sonsuz A; Solakoğlu S; Kiliçaslan I
Leuk Lymphoma; 2002 Mar; 43(3):661-3. PubMed ID: 12002777
[TBL] [Abstract][Full Text] [Related]
77. Clonality in juvenile chronic myelogenous leukemia.
Busque L; Gilliland DG; Prchal JT; Sieff CA; Weinstein HJ; Sokol JM; Belickova M; Wayne AS; Zuckerman KS; Sokol L
Blood; 1995 Jan; 85(1):21-30. PubMed ID: 7803795
[TBL] [Abstract][Full Text] [Related]
78. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
Rosti V; Bergamaschi G; Ponchio L; Cazzola M
Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
[TBL] [Abstract][Full Text] [Related]
79. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
Matolcsy A; Kónya T; Wéber E
Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
[TBL] [Abstract][Full Text] [Related]
80. Agnogenic myeloid metaplasia in children.
Mallouh AA; Sa'di AR
Am J Dis Child; 1992 Aug; 146(8):965-7. PubMed ID: 1636666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
